More about NATCO Pharma Limited

Technicals for NATCO Pharma Limited

The AROON is currently neutral, showing no clear bias toward a rising...

NATCO Pharma Limited's negative gross and operating margins indicate the company is...

The list of all important regulatory filings for NATCO Pharma Limited which...

This article explores the detrimental effects of terrorism on India's economy, highlighting...

The proactive measures taken by Indian airlines in response to the Pahalgam...

This article examines the stock market volatility and investor behavior in India...

Last Updated:

2025-04-25 21:14

Published	Title	Summary
2025-01-30 16:38:38	Board Meeting Intimation	NATCO PHARMA LIMITED has informed the Exchange about Board Meeting...
NATCO PHARMA LIMITED has informed the Exchange about Board Meeting to be held on 12-Feb-2025 to consider and approve the Quarterly Unaudited Financial results of the Company for the period ended December 2024 and Dividend.
2024-08-12 14:07:44	Dividend	Natco Pharma Limited has informed the Exchange that Board of...
Natco Pharma Limited has informed the Exchange that Board of Directors at its meeting held on August 12, 2024, considered Unaudited Financial Results for the quarter ended 30th June, 2024 and declared Interim Dividend of Rs. 3.00 per equity share along with other Agenda Items
2024-07-26 16:06:49	Board Meeting Intimation	NATCO PHARMA LIMITED has informed the Exchange about Board Meeting...
NATCO PHARMA LIMITED has informed the Exchange about Board Meeting to be held on 12-Aug-2024 to consider and approve the Quarterly Unaudited Financial results of the Company for the period ended June 2024 and Dividend.